In small RNA (smRNAs) sequencing studies, highly abundant molecules such as adapter dimer products and tissue-specific microRNAs (miRNAs) inhibit accurate quantification of lowly expressed species. We previously developed a method to selectively deplete highly abundant miRNAs. However, this method does not deplete adapter dimer ligation products that, unless removed by gelseparation, comprise most of the library. Here, we have adapted and modified recently described methods for CRISPR/Cas9-based Depletion of Abundant Species by Hybridization ("DASH") to smRNA-seq, which we have termed miRNA and Adapter Dimer -DASH (MAD-DASH). In MAD-DASH, Cas9 is complexed with sgRNAs targeting adapter dimer ligation products, alongside highly expressed tissue-specific smRNAs, for cleavage in vitro. This process 2 dramatically reduces (>90%) adapter dimer and targeted smRNA sequences, is multiplexable, shows minimal off-target effects, improves the quantification of lowly expressed miRNAs from human plasma and tissue derived RNA, and obviates the need for gel-separation, greatly increasing sample throughput.
INTRODUCTION
Small RNAs (smRNAs) are a diverse class of RNA molecules, including microRNAs (miRNAs), transfer RNAs (tRNAs), small nucleolar RNA (snoRNA), Y-RNA, and many others, that have diverse roles in biological processes (1, 2) . miRNAs are particularly well-studied due to their role as post-transcriptional regulators of gene expression in many biological processes (3) (4) (5) , and altered expression of smRNAs has been implicated in many disease pathologies (6) (7) (8) (9) (10) (11) .
Consequently, there is a need for methods that can precisely and accurately measure smRNAs.
Although smRNAs are measurable with techniques such as qPCR and hybridization based methods, sequencing of smRNA libraries has distinct advantages due to its relative high-throughput and sensitive detection of numerous smRNA species (12) (13) (14) . Additionally, because it allows for agnostic detection of unknown species, novel smRNAs and sequence variation of known smRNAs (such as miRNA isoMirs) can be assessed. Nevertheless, technical challenges in library preparation limit throughput and can lower library quality. In many protocols, documented ligation biases resulting from the use of ATPturnover deficient truncated T4 RNA Ligase 2 and specific adapter sequences combined with preferential ligation of overabundant sequences can limit accuracy and make the detection of non-favored or lowly expressed smRNAs difficult (15) (16) (17) (18) (19) . In addition, the formation of large quantities of unwanted adapter dimer ligation product necessitates time-and labor-intensive removal steps via denaturing gel-electrophoresis, as such dimers are only ~20-30 bp smaller than many desired sequences such as miRNAs.
Targeted reduction of specific sequences from sequencing libraries is frequently employed to enrich for sequences of interest, such as with rRNA-or globin-RNA reduction from mRNA-sequencing libraries. Recently, we and others have demonstrated techniques to deplete specific smRNA sequences from sequencing libraries by using blocking oligonucleotides that prevent 5' adapter ligation, effectively preventing further incorporation of these targets in downstream library construction (20, 21) . While very effective, both strategies have limitations, such as off-targets due to sequence similarity, particularly in the seed region of non-targeted miRNAs with hairpin-oligo blocking. Additionally, neither of these methods address excess adapter dimer ligation products, and thus still require the use of denaturing gel separation of library products before sequencing. Strategies using locked-nucleic acid (LNA) oligos have been employed to prevent adapter dimer formation with some limited success (22) .
Currently, the most effective means of adapter dimer prevention or removal during smRNA sequencing has been demonstrated with ligation free templateswitching protocols or chemically modified adapters that sterically inhibit ligation of the 3' and 5' adapters to each other and inhibit adapter dimer reverse transcription (23, 24) . Because adapter dimer formation is limited, these strategies allow for the use of SPRI-bead based size selection in place of gel separation, which greatly increases library preparation throughput. While very effective at a range of RNA input concentrations, the chemical modifications' efficacy appears to have some adapter-sequence specificity, which, combined with reported necessity of custom reaction conditions, limits their use in other custom or commercial smRNA protocols. In addition, these methods also do not allow for the targeted removal of non-adapter dimer smRNAs, requiring additional experimental methods or greater sequencing depth to allow measurement of lowly abundant smRNAs in the background of a few highly abundant species.
Considering the benefits and limitations of these approaches, a single method that can efficiently remove both unwanted smRNAs and adapter dimer from smRNA libraries in a customizable manner would be tremendously useful.
New genome-and epigenome-editing tools based on repurposing the CRISPR/Cas9 (clustered regularly interspersed short palindromic repeats / Cas9) bacterial immune system have many potential uses (25, 26) . The Cas9 nuclease, when complexed with a short RNA oligonucleotide known as a single guide RNA, or sgRNA, can induce double-stranded breaks (DSBs) at specific sgRNA complementary locations. The low-cost and easily programmable nature of the CRISPR/Cas9 system has led to its use in a variety of applications, such as generation of transgenic animals and cell lines and pooled genome-wide screening (27) (28) (29) Recently, CRISPR/Cas9 has been repurposed as a programmable restriction enzyme to direct cleavage in a more precise and customized manner than conventional restriction enzymes, allowing for innovations in cloning and sequencing of complex repeat regions (30) (31) (32) . Methods using CRISPR/Cas9 as a restriction enzyme have been used to selectively deplete overabundant sequences in a process termed Depletion of Abundant Sequences by Hybridization (DASH) using CRISPR/Cas9 (33) . DASH was used to remove targets such as ribosomal RNA (rRNA) from mRNA-seq and wild-type KRAS background sequence from cancer samples by directing their targeted cleavage and preventing their further amplification and sequencing. Similarly, other groups have applied this process to other assays such as the reduction of mitochondrial DNA from ATAC-seq libraries via CARM (CRISPR-Assisted Removal of Mitochondrial DNA) (34, 35) . Here, we have adapted and modified the DASH method to deplete adapter dimer and highly-abundant miRNAs from smRNA-seq libraries in a process we have termed miRNA and Adapter Dimer -Depletion of Abundant Sequences by Hybridization (MAD-DASH). MAD-DASH effectively removes these sequences either alone or in combination, increasing proportional read depth of non-targeted species and dramatically improving library construction throughput by enabling SPRI bead size-selection instead of denaturing gels. We identify improvements in the rational design of adapter sequences governing MAD-DASH efficacy and demonstrate the utility of this method for blood based, low-input smRNA-seq biomarker studies with the removal of adapter dimer and a known highly abundant erythrocyte contaminant miRNA from human plasma.
METHODS

Total RNA Isolation from Plasma
Peripheral blood sample collections for the isolation of RNA from human plasma were performed as previously described (20) in accordance with the Institutional Review Board at the University of Alabama at Birmingham. Briefly, each collection 5 mL of blood was drawn, centrifuged to isolate plasma and then stored at -80 o C until further use. Total RNA was isolated from 1 mL thawed plasma using the Plasma/Serum Circulating and Exosomal RNA Purification Kit (Slurry Format) (Norgen Biotek) and concentrated to 20 uL using the RNA CleanUp and Concentration Kit (Norgen Biotek). To limit sample variation between MAD-DASH replicate groups, plasma RNA from multiple donors was combined prior to library construction.
Cas9 and MAD-DASH sgRNA preparation
S. pyogenes Cas9 (5 ug/uL, 30 uM) was purchased from PNABio (CPO2). sgRNAs were designed as described in the main text with full sequences listed in Table S1 . sgRNAs were constructed following previously described methods (36 
MAD-DASH Small RNA Sequencing
Small RNA sequencing was performed as described previously (20) 
Data Analysis
Data analysis was performed as previously described (20) with minor modifications to incorporate MAD-DASH specific details. FASTQs were demultiplexed using custom index sequences and adapter sequences were trimmed using Cutadapt (37) . Sequences <15 bp after adapter trimming were separated into a "Short Fail" FASTQ, from which adapter dimer reads (corresponding to a blank sequence line, i.e. trimmed read length of 0 bp) and non-adapter dimer short fail reads were collected. Trimmed reads were aligned to pre-miRNA sequences (miRBase v19 (38)) using Bowtie2 (39) with only two mismatches allowed and keeping only unique best alignments. Mature miRNA counts were determined by counting the aligned pre-miRNA reads overlapping mature mIRNA boundaries using BEDTools (40) . Trimmed reads that did not align to miRNAs contained other smRNA sequences and were designated as "non-miRNA usable reads" for purposes of read fraction calculations. Statistical analysis was performed using the R statistical software package (version 3.4.0). 
Adapter Dimer quantitative PCR in human plasma MAD-DASH libraries
qPCR primers were designed to specifically amplify adapter dimer sequences from either multiplex 5' adapter 1 or the modified 5' adapter and so they would be incapable of amplifying cleaved adapter dimer sequences ( Figure   S2 ). qPCR was performed with Power SYBR Green Master Mix (Invitrogen) in 10 uL reactions using post-PCR2 samples with standard curve using synthetic adapter dimer library to accurately quantify adapter dimer concentration.
Multiplex adapter dimer amounts were multiplied by 4 to account for the other 3 adapter dimer sequences resulting from the equimolar multiplex 5' adapters.
Data analysis was performed using R and comparisons between treated and untreated replicate adapter dimer amounts were performed using an unpaired two-sided Wilcox test with significance set as p<0.05.
RESULTS
Overview of MAD-DASH
To overcome the experimental limitations and low-throughput of our standard smRNA-seq workflow (20) caused by excessive adapter dimer and overabundant miRNAs, we sought to adapt the DASH procedure to smRNA-seq ( Figure 1A ). However, technical differences in smRNA-seq library preparation compared to that of RNA-seq used in DASH required several important modifications to the DASH procedure. A significant benefit of MAD-DASH relative to other adapter dimer depletion methods is the ability to also deplete specific smRNAs from the library.
Similar to depletion of adapter dimer, removal of highly abundant miRNAs such as hsa-miR-16-5p (44) dramatically improves detection of more lowly expressed smRNA species. Utilizing the "CGG" PAM site at the 5' end of our 3' adapter allows for highly specific targeting of smRNAs using their 3'-most ~20 bp sequence ( Figure 1B ) with minimal dependence on adapter nucleotides.
Importantly for miRNA depletion, Cas9 nuclease efficiency is typically more sensitive to mismatches in the 8-12 bp PAM-proximal seed region (45) . Thus, use of the 3' adapter PAM site should improve discrimination between miRNA family members that share the same PAM-distal 5' miRNA seed region. One potential limitation of this 3' adapter PAM choice is the presence of target miRNA 3' isomiRs that have 3' end miRNA sequence variation that can occur due to stochastic DICER pre-miRNA processing or 3' non-templated base addition and would lead to deleterious PAM-proximal sgRNA-target mismatches (46, 47) .
Although this phenomenon is not necessarily a concern for all miRNAs, we devised a modified MAD-DASH sgRNA targeting strategy that shows similar efficacy to the 3' adapter PAM sgRNAs on synthetic miRNA libraries using truncated sgRNAs (48) and amenable miRNA internal PAM sites (present in ~26% of human mature miRNAs annotated in miRBase v21) ( Fig S4) . However, we have found hsa-miR-165p does not contain significant isomiRs in human plasma RNA, and thus all further hsa-miR-16-5p targeting MAD-DASH performed in this study utilized the above 3' PAM adapter strategy.
Finally, we considered the dynamics of the inverse relationship between RNA input amount and adapter dimer formation and its effect on MAD-DASH design. In general, low RNA inputs lead to greater adapter dimer formation, which can be especially pronounced in the ~1-10 ng/uL range of RNA from many common clinical biofluids (often comprising > 90% of the amplified library in our experience). Frequently, the dilution of adapters prior to ligation reactions is employed as a means of reducing adapter dimer formation, even when using chemically modified adapters. However, we find that high molar excess of both 3'
and 5' adapters (10 uM and 20 uM, respectively) is necessary to drive ligation reaction efficiency and more accurate quantification ( Figure S5 ). Conversely, there is a direct relationship to RNA input and targeted miRNA species.
Therefore, both high-and low-RNA inputs will face specific challenges regarding sufficient removal of abundant miRNAs or adapter dimer, respectively. To including MAD-DASH and final library cleanup can be done in a 96-well plate using SPRI beads, throughput is dramatically increased and amenable to automation. We estimate that average library construction time for a full plate of 96 samples (requiring 6 denaturing gels followed by extraction and precipitation in our standard protocol) could be completed in one day for MAD-DASH smRNAseq compared to 3-4 days with our standard protocol.
Evaluating the quantitative performance of MAD-DASH in brain total RNA
To evaluate the effect of reducing adapter dimer and a representative highly-abundant miRNA (hsa-miR-16-5p) both alone and in combination, we generated replicate MAD-DASH no-Cas9/sgRNA control, adapter dimer MAD-DASH, hsa-miR-16-5p MAD-DASH and combined adapter dimer / hsa-miR-16-5p MAD-DASH smRNA-seq libraries and analyzed the normalized abundances of specific sample fractions ( Figure 2A ) as determined by DESeq2 (see Materials and Methods). MAD-DASH significantly depleted adapter dimer (6.5X) and hsa mir-16-5p (52.1X) alone and in combination (7.5X/6.5X), while increasing nonhsa-miR-16-5p miRNA and non-miRNA usable reads as much as 23%. MAD-DASH targeted adapter dimer sequences were depleted to less than 1.6% of total read fraction, while hsa-miR-16-5p was depleted to as little as 0.015% of total read fraction. We limited further in-depth differential expression analysis to changes in miRNAs and adapter dimer sequences because alignment of nonmiRNA smRNAs to the full reference assembly can be complicated (51) and was not expected to demonstrate significantly different results.
Like the effect observed when using our 5' hairpin blocking method (20) , depletion of highly abundant adapter dimer and hsa-miR-16-5p results in increased sensitivity for lowly abundant species ( Figure 2B ). We detected 102 more miRNAs compared to untreated replicates, with as many as 62 more at the commonly used threshold of ten counts per million (CPM). Comparison of significant differential expression between MAD-DASH treated and control replicates demonstrated highly-specific depletion of targeted sequences ( Figure   2C -2E). No significant off-targets were observed when using adapter dimer sgRNAs while hsa-miR-16-5p sgRNA use resulted in only one significant off target, hsa-mir-195-5p. hsa-mir-195-5p is a member of the hsa-mir-16-5p seed region family and shares nearly identical sequence to hsa-mir-16-5p (Table S2) .
Interestingly, when hybridized to an hsa-mir-195-5p library the hsa-mir-16-5p
sgRNA contains a one base pair insertion "bulge" at the PAM -2 site, which appears to be well tolerated and is consistent with prior observations regarding the effect of sgRNA/DNA insertion/deletions on Cas9 nuclease activity (52) .
To demonstrate that the MAD-DASH smRNA-seq workflow's implementation of a SPRI bead cleanup did not negatively affect library reproducibility compared to our standard gel extraction method, we compared the adapter dimer MAD-DASH replicates to gel extracted MAD-DASH noCas9/sgRNA control replicates (size extracted 130bp-200bp) ( Figure 2F ). Only two miRNAs (hsa-miR-22-3p and hsa-miR-9-3p) were significantly altered but had minimal log2 fold-changes (~0.2). While the adapter dimer fraction in the MAD-DASH samples was reduced 6.5-fold to less than 1.6% of the library, it was still roughly 5X more abundant than adapter dimer in the gel extracted samples.
Nevertheless, this level of reduction is likely to be more than sufficient to take advantage of the throughput improvements of the MAD-DASH protocol with minimal increase in cost and sequencing depth.
Rational design of a modified 5' adapter improves MAD-DASH adapter dimer depletion
Although our first iteration of the MAD-DASH smRNA-seq method successfully depletes adapter dimer, we sought to optimize the reduction further through rationally modifying the design of our 5' adapter PAM location. adapter generated considerably more adapter dimer (likely due to less efficient capture of miRNAs caused by only one sequence dictating hybridization and adapter/RNA cofold structure), we were able to deplete adapter dimer 20.3X to less than 1% of the final library. This represents a ~3X greater reduction than in multiplex adapter dimer MAD-DASH samples, and leads to detection of as many as ~101 additional miRNAs (29 at 10 CPM) compared to modified adapter control samples ( Figure S6 ).
Again, comparison of significant differential expression between modified adapter dimer MAD-DASH treated and control replicates demonstrated highly specific depletion, albeit with more off-targets than our multiplex adapter MAD-DASH samples ( Figure 3C ). This is to be expected due to the reduced number of PAM-proximal bases corresponding to the modified adapter's minus strand "CAGC" needed for off target mismatch (6 bp vs 12 bp, i.e. NGG + 4 PAM proximal bases or 10 PAM proximal bases). Significantly altered sequences with log2 fold changes greater >1 (hsa-miR-342-3p, hsa-miR-154-5p and hsa-miR-487-3p) all contained "CCN" corresponding to a target strand "NGG" PAM site in the last 7 bp of their sequence (Table S2) . Interestingly, hsa-miR-487-3p and hsa-miR-342-3p demonstrate a similar insertion/deletion sgRNA/DNA bulge phenomenon to that seen with hsa-miR-195-5p and our hsa-miR-16-5p targeting sgRNA. Importantly, modified adapter dimer MAD-DASH samples have an equivalent reduction in adapter dimer amounts compared to gel extracted control samples with minimal effect on library representation, achieving the desired technical correspondence between our standard smRNA-seq protocol and MAD-DASH smRNA-seq ( Figure 3D ) while dramatically increasing library throughput.
Evaluating MAD-DASH quantitative performance in human plasma RNA
We next sought to demonstrate the utility of MAD-DASH in clinically relevant samples. The detection of circulating smRNAs in human plasma for discovery of diagnostic and prognostic biomarkers is an emerging field. However, as mentioned previously the amount of RNA isolated from patient plasma samples is minimal, on the order of a few ng RNA / mL plasma, leading to low RNA inputs in smRNA-seq and high levels of adapter dimer formation.
Additionally, certain blood cell specific miRNAs such as hsa-miR-16-5p and hsamiR-150 are highly abundant contaminants that limit sensitivity (20, 44) . We therefore applied MAD-DASH smRNA-seq using both our multiplex 5' adapter and our modified 5' adapter strategy to replicate libraries generated from human plasma samples to demonstrate the successful removal of adapter dimer and hsa-mir16-5p and increase detection of lowly abundant species.
Because no-Cas9/sgRNA MAD-DASH control plasma samples yield >95% adapter dimer, dominating the sequencing reads making interpretation impossible, we instead designed a qPCR assay ( Figure S3 ) to quantify the reduction in adapter dimer between MAD-DASH control and treated samples ( Figure 4A ). We observed significant levels of proportional reduction when using either the multiplex 5' adapter (Wilcox P-value < 1.1x10 -3 ) or modified 5' adapter strategy (Wilcox P-value < 7.4x10 -7 ), with the modified 5' adapter MAD-DASH again exhibiting comparatively greater reduction. To confirm specific depletion of highly abundant hsa-miR-16-5p, we sequenced gel-extracted plasma MAD-DASH samples which demonstrated similar specificity to that of brain RNA samples, with only hsa-miR-195-5p as an off-target ( Figure 4B ). In the case of the modified adapter MAD-DASH samples, there was still a significant reduction in residual adapter dimer remaining after gel extraction ( Figure 4C ). These reductions in abundant species yield a dramatic increase in detection of possibly informative, lowly expressed miRNAs ( Figure 4D ) and demonstrate the utility of MAD-DASH for improving the sensitivity of smRNA-seq for lowly-expressed circulating biomarker detection. In principle, extension of MAD-DASH to smRNAseq samples generated from other biofluids such as cerebrospinal fluid should necessitate only the initial detection of non-informative highly abundant sequences to be depleted along with adapter dimer for greatest effect.
DISCUSSION
In this study, we have adapted CRISPR/Cas9 in vitro digestion for the removal of adapter dimer and highly-abundant smRNA species during smRNAseq library preparation. These sequences limit the ability to detect lowlyexpressed smRNAs and in the case of adapter dimer necessitate arduous, lowthroughput denaturing gel size-selection steps. MAD-DASH is a single, simple workflow that renders the need for gel extraction unnecessary in favor of a SPRI bead based size-selection ( Figure 5 ). We estimate that the increased library construction cost when incorporating MAD-DASH is less than $10 per sample using commercially purchased Cas9 and in vitro transcription kits. These costs are likely to be easily covered by the dramatic increase in throughput and ensuing time savings in large scale sequencing projects. This may be particularly true if automation is employed, which MAD-DASH makes possible by allowing for all steps to be performed "on-plate". We have designed and optimized the MAD-DASH protocol specifically for smRNA-seq, though like the original DASH CRISPR/Cas9 in vitro digestion methodology it is inherently generalizable to other library preparation methods with significant adapter dimer amounts.
Frequently, however, adapter dimers are much smaller and more easily separable from insert-containing libraries in other applications, underscoring the special utility of MAD-DASH in smRNA-seq.
We demonstrate that our MAD-DASH smRNA-seq library protocol can deplete adapter dimer and targeted miRNAs with very high specificity that is consistent with known sequence-dependent CRISPR/Cas9 on-/off-target discrimination. We show ability to deplete adapter dimer up to 20X to less than (Table S3) .
Importantly, because MAD-DASH can not only remove adapter dimer but also other abundant smRNAs, it can also yield improvements in smRNA-seq methods already designed to limit adapter dimer formation by using chemically-modified adapters or employing template-switching instead of adapter ligation. Institute for Biotechnology for provided sequencing services and data processing. Figure 1 . Depletion of adapter dimer and overabundant miRNAs with MAD-DASH. (A) MAD-DASH employs Cas9 and adapter dimer-or miRNA-specific sgRNAs to selectively deplete these sequences from final libraries. Cleaved sequences will not amplify during the second round of PCR amplification, and are also no longer suitable substrates for bridge amplification during Illumina sequencing (though they will still be able to bind to the flow-cell using the P5/P7 sequences remaining on each cleaved library). (B) Design of adapter dimer and hsa-miR-16-5p sgRNAs using available pre-existing PAM sites on our smRNA- Adapter dimer targeting sgRNAs use a minus strand "NGG" and have ten base pairs of homology to both the 5'-and 3' adapter, ensuring target cleavage specificity for adapter dimer sequences. hsa-miR-16-5p uses a 3' PAM site one base away from the 3' -adapter ligation junction, which can be generalized to other smRNAs and provides highly-specific targeting while minimizing off-targets. Shown are only the plus strand of non-PCR tailed sequences. Green boxes indicate the plus strand sequence corresponding to sgRNA location in the dsDNA library, while the yellow box indicates the plus strand location of the "NGG" PAM in the dsDNA library. sgRNA location is depicted in blue along with the three 5' "G" nucleotides necessary for high levels of T7 in vitro transcription. MAD-DASH treated and control MAD-DASH smRNA-seq replicates made using the multiplex adapter and targeting adapter dimer and hsa-mir-16-5p alone and in combination. As in (C), MAD-DASH samples targeting adapter dimer alone and combined with hsa-mir-16-5p depict increased sensitivity even when performing gel extraction. Downsampling and CPM normalization was performed as described in Materials and Methods. Figure 5 . Illustration of standard smRNA-seq (A) and MAD-DASH smRNA-seq (B) workflows. While MAD-DASH involves an extra PCR amplification in addition to the MAD-DASH CRISPR/Cas9 in vitro digestion, the extra ~3 hours to accomplish this relative to finishing the PCR in our standard protocol are more than offset by no longer needing to perform gel extraction, DNA recovery and library concentration. For nearly a hundred samples, we estimate that researcher time for smRNA-seq library construction can be reduced to only 1 day using MAD-DASH smRNA-seq and that this throughput can be further improved with greater protocol familiarity or automation. Figure S2 . Design of adapter dimer qPCR primers to assess adapter dimer concentrations after PCR2. A consistent forward primer to amplify both multiplex and modified adapter dimers was designed, with adapter specificity coming from the reverse primer. The reverse primers were designed to both incorporate some amount of 5' adapter and 3' adapter sequences while also spanning the MAD-DASH CRISPR/Cas9 mediated double-stranded break, such that they had only four base pairs with which to anneal to non-cleaved adapter dimer, which prevents non-specific amplification of non-adapter dimer species. Furthermore, mismatches in the 3' head of primers are typically result in no or inefficient amplification. Matching Off-target sequences with other sequences in the library would require significant sequence homology and would not be expected to vary between treated and untreated samples. Supplementary Figure S6 . Plot depicting the difference in the number of mature miRNA species reaching a specified count per million threshold between either multiplex or modified adapter dimer MAD-DASH smRNA-seq replicates and their respective no-Cas9/sgRNA MAD-DASH control replicates. Downsampling and CPM normalization was performed as described in Materials and Methods. 
FIGURES AND TABLES
Supplementary
